carbapenems has been researched along with Cystitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angoulvant, F; Bontemps, S; Cohen, R; Dessein, R; Dubos, F; Lagree, M; Madhi, F; Martinot, A | 1 |
| Asadi Karam, MR; Bouzari, S; Habibi, M; Shahbazi, S; Talebi, A | 1 |
| Naber, KG; Wagenlehner, FME | 1 |
| Doi, Y; Qureshi, ZA | 1 |
1 review(s) available for carbapenems and Cystitis
| Article | Year |
|---|---|
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
3 other study(ies) available for carbapenems and Cystitis
| Article | Year |
|---|---|
Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Cystitis; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospitals, University; Humans; Inappropriate Prescribing; Male; Practice Patterns, Physicians'; Pyelonephritis; Retrospective Studies; Secondary Care Centers; Surveys and Questionnaires; Urinary Tract Infections | 2018 |
Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Quinolones; Uropathogenic Escherichia coli; Virulence; Virulence Factors; Young Adult | 2018 |
Novel Antibiotics in the Treatment of Urinary Tract Infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections | 2019 |